Département Anesthésie Réanimation, Service de Gynécologie et Obstétrique, AP-HP, Hop Bichat-Claude Bernard, Univ Paris Diderot, Sorbonne Paris Cité, Paris, France.
Anesth Analg. 2013 Feb;116(2):392-8. doi: 10.1213/ANE.0b013e3182768f78. Epub 2013 Jan 9.
Marfan's syndrome is characterized by progressive dilatation of the aortic root. This dilatation is accelerated by pregnancy, exposing patients to an increased risk of aortic dissection. Literature on the anesthetic management of delivery in patients with Marfan's syndrome consists only of case reports. We therefore conducted a retrospective review of medical records focusing on anesthetic management of delivery in patients with Marfan's syndrome in a national referral center.
We reviewed the medical records of all pregnant women with Marfan's syndrome who were followed at their institution over a 6-year period.
Sixteen pregnancies in 15 patients were analyzed. The initial aortic root diameter was larger than 40 mm in 9 patients and larger than 45 mm in 1 patient. Two patients did not receive β-blockers throughout pregnancy because of poor tolerance. One patient with an aortic root diameter of 47 mm did not receive β-blocker before 33 weeks' gestation because of late referral. This woman developed acute type 1 aortic dissection at 37 weeks, requiring emergency cesarean delivery under general anesthesia followed by aortic repair. Thirteen other patients underwent cesarean delivery, 1 under spinal anesthesia and 12 under general anesthesia. General anesthesia management included close arterial blood pressure monitoring, avoidance of high blood pressure, administration of opioids before delivery, and titrated nicardipine administration. Two patients (including one with intrauterine fetal death) underwent vaginal delivery under epidural analgesia. There were no maternal deaths.
Pregnant women with Marfan's syndrome who received care in a multidisciplinary tertiary care setting that included active peripartum involvement of anesthesiologists had good clinical outcomes.
马凡综合征的特征是主动脉根部进行性扩张。这种扩张会因妊娠而加速,使患者面临更大的主动脉夹层风险。关于马凡综合征患者分娩的麻醉管理的文献仅包括病例报告。因此,我们在一家国家转诊中心对马凡综合征患者的分娩麻醉管理进行了回顾性病历审查。
我们回顾了在该机构接受随访的 6 年内所有患有马凡综合征的孕妇的病历。
分析了 15 名患者的 16 例妊娠。9 例患者的初始主动脉根部直径大于 40mm,1 例患者的初始主动脉根部直径大于 45mm。由于不耐受,2 名患者在整个孕期均未服用β受体阻滞剂。1 例主动脉根部直径为 47mm 的患者由于转诊较晚,在 33 周妊娠前未服用β受体阻滞剂。该患者在 37 周时发生急性 1 型主动脉夹层,需要在全身麻醉下紧急剖宫产,并随后进行主动脉修复。其他 13 名患者接受了剖宫产,1 例采用脊髓麻醉,12 例采用全身麻醉。全身麻醉管理包括密切监测动脉血压、避免高血压、在分娩前给予阿片类药物,并滴定尼卡地平给药。2 例(包括 1 例宫内胎儿死亡)在硬膜外镇痛下经阴道分娩。没有产妇死亡。
在多学科三级保健环境中接受治疗的马凡综合征孕妇,包括麻醉医生积极参与围产期管理,其临床结局良好。